OBJECTIVE: To determine in three samples of obese women the prevalence of two eating disorders--binge eating disorder and the night-eating syndrome. METHOD: Interviews utilizing standard criteria. For binge eating disorder: the consumption of large amounts of food in a discrete period of time together with a subjective sense of loss of control and no vomiting or laxative abuse. For the night-eating syndrome: morning anorexia, evening hyperphagia and insomnia. Determining the rate of binging among patients receiving a placebo. SUBJECTS: (1) 102 viewers of a television show describing binge eating disorder; (2) 50 participants in a trial of medication for this disorder and (3) 79 participants in a weight reduction program. RESULTS: In the television sample 19.6% of respondents and in the weight reduction sample 7.6% met criteria for binge eating disorder; all subjects in the medication sample met criteria. During a 4-week placebo period average binge frequency fell from 6.0 to 1.7 binges per week. The night-eating syndrome was manifested by 13.7% of the television sample, 8.9% of the weight reduction sample and 15.0% in the medication trial sample. There was little overlap between the two disorders. CONCLUSIONS: Binge eating disorder is far less frequent than has been believed on the basis of questionnaire studies and it is highly responsive to placebos. Frequency of the night-eating syndrome is comparable to that of binge eating disorder. Future studies should assess binge eating disorder by interview rather than by self-administered questionnaire.
OBJECTIVE: To determine in three samples of obesewomen the prevalence of two eating disorders--binge eating disorder and the night-eating syndrome. METHOD: Interviews utilizing standard criteria. For binge eating disorder: the consumption of large amounts of food in a discrete period of time together with a subjective sense of loss of control and no vomiting or laxative abuse. For the night-eating syndrome: morning anorexia, evening hyperphagia and insomnia. Determining the rate of binging among patients receiving a placebo. SUBJECTS: (1) 102 viewers of a television show describing binge eating disorder; (2) 50 participants in a trial of medication for this disorder and (3) 79 participants in a weight reduction program. RESULTS: In the television sample 19.6% of respondents and in the weight reduction sample 7.6% met criteria for binge eating disorder; all subjects in the medication sample met criteria. During a 4-week placebo period average binge frequency fell from 6.0 to 1.7 binges per week. The night-eating syndrome was manifested by 13.7% of the television sample, 8.9% of the weight reduction sample and 15.0% in the medication trial sample. There was little overlap between the two disorders. CONCLUSIONS:Binge eating disorder is far less frequent than has been believed on the basis of questionnaire studies and it is highly responsive to placebos. Frequency of the night-eating syndrome is comparable to that of binge eating disorder. Future studies should assess binge eating disorder by interview rather than by self-administered questionnaire.
Authors: Kelly C Allison; Scott G Engel; Ross D Crosby; Martina de Zwaan; John P O'Reardon; Stephen A Wonderlich; James E Mitchell; Delia Smith West; Thomas A Wadden; Albert J Stunkard Journal: Eat Behav Date: 2008-05-10
Authors: Albert J Stunkard; Kelly C Allison; Allan Geliebter; Jennifer D Lundgren; Marci E Gluck; John P O'Reardon Journal: Compr Psychiatry Date: 2008-11-26 Impact factor: 3.735
Authors: P J Vamado; D A Williamson; B G Bentz; D H Ryan; S K Rhodes; P M O'Neil; S B Sebastian; S E Barker Journal: Eat Weight Disord Date: 1997-09 Impact factor: 4.652
Authors: L Busetto; M Mazza; S Salvalaio; F De Stefano; M Marangon; E Calò; S Sampietro; G Enzi Journal: Eat Weight Disord Date: 2009 Jun-Sep Impact factor: 4.652
Authors: Kelly C Allison; Scott J Crow; Rebecca R Reeves; Delia Smith West; John P Foreyt; Vicki G Dilillo; Thomas A Wadden; Robert W Jeffery; Brent Van Dorsten; Albert J Stunkard Journal: Obesity (Silver Spring) Date: 2007-05 Impact factor: 5.002